Few studies have been performed on the mortality rates of either form of hyperaldosteronism, but 10-year-survival rates have been reported between 90% - 95% in patients treated. The most common morbidity associated with this disorder is cardiovascular. Cardiovascular mortality is increased in these patients, but all-cause mortality is not significantly different.

If hypokalemia persists, it may lead to weakness, paralysis, constipation, and polyuria. Hypokalemia also impairs the secretion of insulin and promotes the development of diabetes mellitus.